tirzepatide surmount-1 nejm 2022 weight loss percent Weekly subcutaneous yields substantial in patients with or without diabetes. Weight reductions with higher doses approach those seen with bariatric surgery. https://t.co/YvcX73VCis @NEJM GLP-1R Agonists for Weight Loss
Description
Quality verification should include HPLC and mass spectrometry testing confirming identity and purity
Most clients begin to see results within the first few weeks , with more noticeable weight loss around weeks 4 to 8
Using proper reconstitution techniques and sourcing from reputable compounding pharmacies helps ensure equivalent safety
Discontinuing either medication often results in weight regain, highlighting that obesity is a chronic disease requiring ongoing management
How it works Mounjaro's active ingredient is tirzepatide, a unique combination that targets two key hormones: GLP-1 and GIP
174.Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, Van Belle G, et al
